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Human exposure to chemical compounds, often termed xenobiotics, has been linked to a
number of enhanced incidences of various neoplasias. A majority of these enter the human body
through inhalation. Most xenobiotics are metabolized in the body to more hydrophilic metabolites
before excretion in the urine and bile. During this process, promutagens and procarcinogens
could be activated and could interact with proteins as well as DNA to form adducts. DNA adducts
formed by chemical carcinogens can, therefore, be used as biomarkers of exposure and other
host factors. This study shows that DNA adduct analysis can be performed on cells from human
nasal mucosa. Using the nasal lavage procedure performed on 20 healthy volunteers, 5 x 105 to
5 x 106 cells were obtained from which 5 to 40 pg DNA was isolated. DNA adducts were analyzed
by the 32P-postlabeling assay. The DNA adduct levels ranged between 1.4 and 6 adducts/106
nucleotides. In addition to its simplicity, the nasal lavage procedure is an inexpensive, noninvasive
procedure that requires no anesthetics or special equipment. Moreover, the cells obtained are the
first to come in contact with air pollutants. DNA adduct analysis from human nose mucosa cells
could therefore be used to develop a technique suitable for the assessment of exposure to
chemical carcinogens through inhalation. - Environ Health Perspect 104(Suppl 3):471-473 (1996)
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Introduction
The exponential increase in the production
and use of chemicals has had a profound
impact on the environment and created
unforeseen hazards to man's well-being.
Many ofthose compounds, termed xenobi-
otics, are not water soluble and thus must
be metabolized in the body to more polar
metabolites (biotransformation) prior to
excretion in the urine and bile. Usually this
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series ofevents is considered to be a mech-
anism invented by nature to detoxify dele-
terious compounds; however, in some cases
during biotransformation, reactive inter-
mediates can be produced and can either
uncouple integrated biochemical processes
or combine covalently with cellular con-
stituents such as DNA, RNA, and protein.
It is now evident that carcinogenesis,
mutagenesis, and cellular necrosis are often
attributable to the action ofsuch reactive
intermediates (1-5). DNA adduct forma-
tion is therefore thought to represent an
early and critical step in the process of
chemical carcinogenesis; thus, it is reason-
able to assume that human populations
with chronically elevated DNA adduct
levels may be at higher risk ofdeveloping
cancer (6-8). DNA adducts formed in
human cells by chemical carcinogens
can be used as biomarkers and dosimeters
ofexposure.
Because humans are predominantly
nose breathers and the ventilation rates
through the nasal passages can exceed
10,000 liters per day, the cells lining the
nasal passages are the first to come in con-
tact with air pollutants. These cells also
constitute the first line of defense against
various xenobiotics. There is therefore every
reason to believe that inhaled airborne pol-
lutants might provide adverse effects on the
nose mucosa cells. The cells in human nasal
cavity could, however, be an excellent mate-
rial for the development of biomarkers
related to airborne carcinogens. The main
goal ofthis study has been to determine if
samples provided by the nasal lavage proce-
dure contain sufficient amount ofDNA for
assessing and quantifying DNA adducts.
Materials and Methods
Subjects
Nasal mucosa cells were collected from 20
healthy volunteers from our institute. All
the subjects had a normal-appearing nasal
mucosa; subjects with ongoing symptoms
ofnasal diseases or ongoing drug treatment
were excluded from this study.
Cell andNudeus Isolation
Nasal mucosal cells were isolated by the
nasal lavage procedure as described previ-
ously (9). Briefly, nasal lavage was per-
formed with 10 ml sterile isotonic saline
solution (0.9%), 5 ml in each nasal cavity,
using a needleless syringe while the subject
gently flexed his head backward and did
not breathe or swallow. The saline was held
in the nasopharyngeal region by palatal
pressure for 10 sec; the subject then
forcibly expelled the nasal lavage fluid
containing mucosal cells into a collection
vessel. The lavage fluid from each subject
(8 ml) was rapidly transferred into Falcon
tubes to which 0.8 ml acetylcystein (200
mg/ml, a mucus digestant purchased from
Kabi Pharmacia, Stockholm, Sweden) was
added and incubated at room temperature
for 30 min with a shaking frequency of
100 cycles/min. After this incubation, the
volume oflavage fluid was adjusted to 10
ml and a 0.5 ml aliquot was taken out for
the total cell counting (monitored in a
hemocytometer). The remaining sample
(9.5 ml), which was used for DNA isola-
tion, was centrifuged at 2,000xg for 10
min. The resulting cell pellets were
suspended in 5 ml ofa medium composed
of 5% Triton X (polyethylene glycol
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p-isooctylphenyl ether), 75 mM NaCl, and
10 mM Tris-HCl (pH 7.4). To obtain the
cell nucleus, the cell suspensions were
shaken vigorously for 10 min at room tem-
perature and then centrifuged at 2,000xg
for 10 min. The nuclear pellet was resus-
pended in 200 ili buffer containing 75 mM
NaCl and 10 mM Tris-HCI (pH 7.4) and
stored at-20°C until isolation ofDNA.
Purificaion ofDNAand
32P-posdtabelingAnalysis ofAdducts
DNA was isolated from nuclei using a
standard procedure involving enzymatic
digestion ofRNA and protein by treatment
with pancreatic ribonuclease and pro-
teinase K followed by extraction with phe-
nol and chloroform:isoamyl alcohol (24:1)
as described earlier (10). Isolated DNAwas
quantitated spectrophotometerically by
measuring the absorption at 260 nm and
assuming 20 OD/mg DNA. The 260/280
ratios for DNA samples ranged from 1.5 to
1.6. DNA (1-5 pg) was digested into nor-
mal deoxynucleosides and adducts by
nuclease P1-mediated procedure (11).
Digested DNA was labeled with 7 pCi of
y-32P-ATP (3,000 Ci/mmol), and the
adducts were analyzed by multidirectional
thin-layer chromatography as described
earlier (12,13).
Results
As shown in Table 1, 2 x 106 cells were
obtained from each nasal lavage from
which DNA was isolated. The analyses
were performed on 20 healthy volunteers
from 25 to 55 years of age. The levels of
adducts detected in this study ranged
between 1.4 and 6.0 adducts/108 nucleo-
tides with a mean of3 adducts/108 nucleo-
tides. Since the purity ofthe isolated DNA
was relatively low (260/280 ratios for DNA
samples; range 1.5-1.6), it is indicated that
the adduct levels are underestimated.
Adduct patterns from three individuals
are shown in Figure 1. The adduct spots
seem to vary among individuals, which
may be related to the distribution of the
cells collected, smoking habit, etc. So far,
the material is too small to point out the
variables that affect the quantity and pattern
ofadducts ofthe nasal cells.
Discussion
Because it is the first site of air entry, the
nasal cavity is a primary target for effects
Table 1. Cell number, DNA content, and DNA adduct
level from human nasal lavage fluid.a
Mean Range
Number of cells 2x106 5x105-5x106
DNA(pg) 19 5-40
DNA adduct levelb 3 1.4-6.0
'Means of 20 healthy unexposed individuals. bAdducts
per 108 nucleotides.
from environmental contaminants (14).
To protect the lower airways from airborne
chemical toxicants, the cells lining the
nasal passages are furnished with a very
effective defense system. Thus, the human
nasal mucosa contains high levels ofxeno-
biotic-metabolizing enzymes, e.g., cyto-
chrome P450 isozymes, epoxide hydrolase,
glutathione S-transferase, and DT-dia-
phorase (15,16). High levels ofxenobiotic-
metabolizing enzymes have also been
detected in other mammalian species such
as rat, mouse, rabbit, hamster, monkey,
etc. (17-20). These high levels ofxenobi-
otic-metabolizing enzymes are probably
necessary to rapidly metabolize and remove
the inhalated xenobiotics; however, pro-
mutagens and procarcinogens could be
activated by this nasal biotransformation
and interact with proteins as well as DNA,
forming DNA adducts.
During the last decade, extremely sensi-
tive methods for assessing and quantifying
DNA adducts have been developed (6,7).
Because ofits high sensitivity with certain
adducts (1 adduct/1010 nucleotides), the
low amount ofDNA needed for each assay
(1-5 pg DNA), and its applicability to
almost all hydrophobic DNA adducts, the
32P-postlabeling assay has emerged as a
suitable method for specimens from
humans exposed to environmental mixtures
ofcarcinogens and mutagens (6,7).
This study was designed to investigate
ifthe cells obtained from the human nasal
mucosa contain a sufficient amount of
DNA for adduct analysis. The results pre-
sented here demonstrate that, from each
nasal lavage procedure, 5 to 40 pg DNA
can be isolated. It is therefore suggested
that nasal cells obtained by this procedure
provide a sufficient amount of DNA for
DNA adduct analysis on a routine basis. In
addition, the nasal lavage procedure is a
simple, inexpensive, and noninvasive proce-
dure that requires no anesthetics or special
equipment and provides human tissue,
Figure 1. Typical pattern of DNA adducts of the nasal
cells from three individuals. Adducts were derived from
5 pg of DNA.
which is the first target of and the first
line of defense against airborne chemical
carcinogens. By combining the sensitivity
of the 32P-postlabeling assay with the
specificity of the nasal mucosa to the air-
borne chemical exposures, the DNA adduct
analysis from human nasal mucosa cells
represents an ideal technique in the assess-
ment ofexposure to airborne chemical car-
cinogens. Further work however is needed
in order to evaluate the above technique in
comparison with results obtained from
other tissues from the same individuals,
e.g., isolated lymphocytes.
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